Galderma Group AG (CHIX:GALDZ) FCF Margin % : -1.90% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Galderma Group AG's Free Cash Flow for the six months ended in Jun. 2024 was CHF-38 Mil. Galderma Group AG's Revenue for the six months ended in Jun. 2024 was CHF1,981 Mil. Therefore, Galderma Group AG's FCF Margin % for the quarter that ended in Jun. 2024 was -1.90%.

As of today, Galderma Group AG's current FCF Yield % is -0.18%.

The historical rank and industry rank for Galderma Group AG's FCF Margin % or its related term are showing as below:

CHIX:GALDz' s FCF Margin % Range Over the Past 10 Years
Min: -1.9 Med: 0 Max: 0
Current: -1.9

CHIX:GALDz's FCF Margin % is ranked worse than
58.35% of 994 companies
in the Drug Manufacturers industry
Industry Median: 0.9 vs CHIX:GALDz: -1.90

Galderma Group AG FCF Margin % Historical Data

The historical data trend for Galderma Group AG's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG FCF Margin % Chart

Galderma Group AG Annual Data

Trend

FCF Margin %

Galderma Group AG Semi-Annual Data
	Jun23	Jun24
FCF Margin %	-12.11	-1.90

Competitive Comparison of Galderma Group AG's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galderma Group AG's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's FCF Margin % falls into.

Galderma Group AG FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Galderma Group AG's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin	=	Free Cash Flow (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Galderma Group AG's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-37.54	/	1980.661
	=	-1.90 %

Galderma Group AG FCF Margin % Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Galderma Group AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

GALDY:USA GDERF:USA GALD:Switzerland

Address

Zahlerweg 10, Zug, CHE, 6300

Website

https://www.galderma.com

Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines